Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 47 (4) , 479-484
- https://doi.org/10.1016/0049-3848(87)90463-4
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Congenital Deficiency of Cyclo-Oxygenase in a Woman with Generalized AtherosclerosisScandinavian Journal of Haematology, 2009
- Alteration of Prostanoids in AtherosclerosisSeminars in Thrombosis and Hemostasis, 1985
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Increased production of platelet thromboxane B2 in non‐insulin‐dependent diabetes. Relationship to vascular complicationsEuropean Journal of Clinical Investigation, 1984
- Thromboxane B2, 6-keto-PGF1α, PGE2, PGF2α, and PGA1 plasma levels in arteriosclerosis obliterans: Relationship to clinical manifestations, risk factors, and arterial pathoanatomyAmerican Heart Journal, 1984
- Prostaglandins and the cardiovascular system.Heart, 1983
- Biology and therapeutic potential of prostacyclin.Stroke, 1983
- Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary hear diseasesProstaglandins, 1981
- ALTERATION IN THE BALANCE OF PROSTAGLANDIN AND THROMBOXANE SYNTHESIS IN DIABETIC RATS1980
- CIRCULATING PROSTACYCLIN MAY BE REDUCED IN DIABETESThe Lancet, 1979